NO AND ESTRADIOL SUSTAINED NEURONAL DIFFERENTIATION

NO 和雌二醇维持神经元分化

基本信息

项目摘要

DESCRIPTION: (provided by applicant) The long-term objective of this proposal is to study the molecular mechanism(s) of fetal neuronal development and neuronal differentiation under the effects of the female hormone, estradiol (E2). The investigators hypothesize that E2 induced nNOS is an important molecular mediator of E2 mediated sustenance of neuronal differentiation in NGF-withdrawal PCl2 cells. This hypothesis will be tested under the following specific aims: to determine the molecular mechanism by which E2 sustains neuronal differentiation and neurite outgrowth of PCl2 cells, derived originally from a rat pheochromocytoma, by determining whether E2-induced NO is required for the continued differentiation program; and to identify the cis-acting response elements in the nNOS promoter, the transcription factors that transactivate the nNOS gene, and the signaling transduction pathways required for estrogen-mediated induction of nNOS gene expression. These experiments will direct future studies critical to the understanding of E2- mediated fetal neuronal development and neuronal differentiation, that will lend insights into the approach to neurodegenerative diseases. In order to achieve these goals, the research design and methods will include the PC12 cell line, which is widely used as a model system to study NGF- mediated neuronal differentiation. The E2 mediated molecular mechanisms which participate in sustaining PCl2 cell differentiation following NGF-withdrawn are not known. Blocking production of Nitric Oxide (NO) with an inhibitor of NOS, N (omega)-nitro-L-arginine methyl ester (L-NAME), but not D-NAME, inhibits neurite extension, implicating nNOS in the differentiation process. E2, like NGF, markedly induces nNOS activity and mRNA levels in neuronal cells and anti-estrogen drugs act as strong inhibitors of purified nNOS, suggesting that E2 may sustain neuronal differentiation and neurite growth via an NO- mediated process. Based on these observations, the investigators hypothesize that E2 induced nNOS is an important molecular mediator of E2 mediated sustenance of neuronal differentiation in NGFwithdrawal PCl2 cells.
描述:(由申请人提供)本提案的长期目标

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBIN FARIAS-EISNER其他文献

ROBIN FARIAS-EISNER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBIN FARIAS-EISNER', 18)}}的其他基金

Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
查尔斯德鲁大学/加州大学洛杉矶分校癌症中心合作消除癌症健康
  • 批准号:
    8136941
  • 财政年份:
    2009
  • 资助金额:
    $ 7.65万
  • 项目类别:
Planning and Evaluation Core
规划与评估核心
  • 批准号:
    9041141
  • 财政年份:
    2009
  • 资助金额:
    $ 7.65万
  • 项目类别:
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
查尔斯德鲁大学/加州大学洛杉矶分校癌症中心合作消除癌症健康
  • 批准号:
    8308607
  • 财政年份:
    2009
  • 资助金额:
    $ 7.65万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9041140
  • 财政年份:
    2009
  • 资助金额:
    $ 7.65万
  • 项目类别:
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
查尔斯德鲁大学/加州大学洛杉矶分校癌症中心合作消除癌症健康
  • 批准号:
    8908092
  • 财政年份:
    2009
  • 资助金额:
    $ 7.65万
  • 项目类别:
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
(2/2) CDU/UCLA 癌症中心合作消除癌症健康差异
  • 批准号:
    9150607
  • 财政年份:
    2009
  • 资助金额:
    $ 7.65万
  • 项目类别:
Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health
查尔斯德鲁大学/加州大学洛杉矶分校癌症中心合作消除癌症健康
  • 批准号:
    8543589
  • 财政年份:
    2009
  • 资助金额:
    $ 7.65万
  • 项目类别:
NO AND ESTRADIOL SUSTAINED NEURONAL DIFFERENTIATION
NO 和雌二醇维持神经元分化
  • 批准号:
    6536319
  • 财政年份:
    2001
  • 资助金额:
    $ 7.65万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    9152247
  • 财政年份:
  • 资助金额:
    $ 7.65万
  • 项目类别:
Research Education Core
研究教育核心
  • 批准号:
    9152255
  • 财政年份:
  • 资助金额:
    $ 7.65万
  • 项目类别:

相似海外基金

An atypical microtubule generation mechanism for neurons drives dendrite and axon development and regeneration
神经元的非典型微管生成机制驱动树突和轴突的发育和再生
  • 批准号:
    23K21316
  • 财政年份:
    2024
  • 资助金额:
    $ 7.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Characterizing Wnt Signaling Pathways in Axon Guidance
轴突引导中 Wnt 信号通路的特征
  • 批准号:
    10815443
  • 财政年份:
    2023
  • 资助金额:
    $ 7.65万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 7.65万
  • 项目类别:
Does phosphorylation regulation of the axon initial segment cytoskeleton improve behavioral abnormalities in ADHD-like animal models?
轴突起始段细胞骨架的磷酸化调节是否可以改善 ADHD 样动物模型的行为异常?
  • 批准号:
    23KJ1485
  • 财政年份:
    2023
  • 资助金额:
    $ 7.65万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Loss-of-function variants of the axon death protein SARM1 and protection from human neurodegenerative disease
轴突死亡蛋白 SARM1 的功能丧失变体和对人类神经退行性疾病的保护
  • 批准号:
    2891744
  • 财政年份:
    2023
  • 资助金额:
    $ 7.65万
  • 项目类别:
    Studentship
Collaborative Research: Evolution of ligand-dependent Robo receptor activation mechanisms for axon guidance
合作研究:用于轴突引导的配体依赖性 Robo 受体激活机制的进化
  • 批准号:
    2247939
  • 财政年份:
    2023
  • 资助金额:
    $ 7.65万
  • 项目类别:
    Standard Grant
Understanding the degeneration of axon and nerve terminals in Alzheimer's disease and related dementia brain
了解阿尔茨海默病和相关痴呆大脑中轴突和神经末梢的变性
  • 批准号:
    10661457
  • 财政年份:
    2023
  • 资助金额:
    $ 7.65万
  • 项目类别:
Unlocking BIN1 function in oligodendrocytes and support of axon integrity
解锁少突胶质细胞中的 BIN1 功能并支持轴突完整性
  • 批准号:
    10901005
  • 财政年份:
    2023
  • 资助金额:
    $ 7.65万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 7.65万
  • 项目类别:
The role of RNA methylation in cytoskeleton regulation during axon development
RNA甲基化在轴突发育过程中细胞骨架调节中的作用
  • 批准号:
    22KF0399
  • 财政年份:
    2023
  • 资助金额:
    $ 7.65万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了